BioNTech is a German biotechnology company known for its mRNA COVID-19 vaccine (with Pfizer) and its mRNA-based cancer and infectious-disease pipeline.
Brookfield Wealth Solutions Ltd. (BNT) is expected to report earnings on Wednesday, October 28, 2026, after the close.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-13 | Jun 2026 qtr | — | $0.40 | — | $4.11B |
| 2026-03-31 | Dec 2025 qtr | $0.00 | $-2.25 | — | $1.63B |
| 2025-12-31 | Sep 2025 qtr | — | $0.01 | — | $3.10B |
| 2025-09-30 | Jun 2025 qtr | $0.00 | $1.91 | — | $3.11B |
| 2025-06-30 | Mar 2025 qtr | $0.00 | $1.76 | — | $2.91B |
| 2025-03-31 | Dec 2024 qtr | $0.00 | $-1.34 | — | $2.42B |
| 2024-12-31 | Sep 2024 qtr | $0.00 | $3.61 | — | $5.98B |
| 2024-09-30 | Jun 2024 qtr | $0.00 | $0.16 | — | $2.75B |
Highlights from BNT's Aug 13 report: EPS of $0.40; revenue of $4.11B. Focus now shifts to pipeline readouts and mRNA/oncology partnership progress.
See BNT on the live calendar →